Harvard Business Review

MAY 20, 2014

As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. When a company had dozens of potential competitors in various geographic regions, there was an incentive to innovate before the other guy does. Economy Entrepreneurship Finance'

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

MAY 26, 2014

Four dynamics are driving this new era of health care innovation: Finally, there is a financial incentive to innovate. Top-tier thinkers from data science, business, finance, and the digital world are coming together to find new solutions. billion in 2013, up 39% from 2012. Entrepreneurship Health Innovation'

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2013

noted the irony that because of sequester cuts, NIH funding was reduced for the research that resulted in Yale’s James Rothman sharing in the 2013 Nobel Prize for Medicine. Cuts to 2013 budget : $285 Million or 5%. Cuts to 2013 budget: $11.08 Cuts to 2013 budget : $209 Million or 5%. Leading Health Care Innovation.

Health Care 8

Health Care Budgeting Pharmaceuticals Review 8